Full Press Release Details
Butterfly Network, Inc. Further Strengthens
Management and Board with Key Additions
Stacey Pugh joins Butterfly as Chief Commercial
Dr. Elazer Edelman joins Butterfly's
GUILFORD, Conn. and NEW YORK, New York, March 11, 2021
Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"),
an innovative digital health company driving universal access to superior medical imaging, today announced the appointment of Stacey
Pugh as Chief Commercial Officer, effective March 15th. In this newly created executive position, Ms. Pugh will oversee
the development and implementation of Butterfly's commercial strategy to ensure optimal value capture for Butterfly's
unique imaging technology and clinical solutions.
"Stacey is a highly accomplished commercial leader with
a track record of introducing novel technologies into the market on a global scale, as well as a trained critical care and trauma
nurse with a passion for patient care. She is uniquely positioned to leverage her extensive business and medical experience as
Butterfly drives commercial growth and makes ultrasound more accessible and deployable across a variety of care settings,"
said Dr. Todd Fruchterman, President and Chief Executive Officer of Butterfly. "I am excited for Stacey to join the team
as we progress towards fulfilling our mission to deliver innovative ultrasound technology that is easy to use, integrates
into clinical decision-making workflows, and ultimately lowers the cost of care."
Ms. Pugh brings to Butterfly her extensive leadership experience
in developing and commercializing medical technologies and building world-class teams. She has held leadership positions across
sales, marketing, medical affairs, and business development during her 18 plus year career at medical device manufacturers Medtronic,
Covidien and Kinetic Concepts. Ms. Pugh joins Butterfly from Medtronic where she served as SVP and President of Medtronic's
Neurovascular business area. In this role, she oversaw global development through commercialization and was responsible for P&L
management and revenue growth. Prior to this, she spent nearly eight years in a variety of clinical development roles at Kinetic
Concepts, and the early years of her career in critical care, trauma nursing and nursing education.
"I am excited to partner with Todd and the team at Butterfly
to drive market penetration of this breakthrough technology across clinical applications, care settings and geographies,"
said Stacey Pugh. "Butterfly has the potential to improve the health of millions of patients while empowering nurses, doctors
and other medical professionals to more quickly, confidently, and conveniently diagnose and monitor health and drive wellness."
In addition, Butterfly's Board of Directors has expanded
to eight directors through the appointment of Elazer Edelman, M.D., Ph.D., as Butterfly continues to deepen the medical, engineering
and operational experience of its Board. Dr. Edelman, who heads the Edelman lab, the Harvard - MIT Biomedical Engineering
Center and is a practicing physician, will further strengthen the Board's perspective in the areas of technology development,
clinical applications and strategy.
"Elazer has dedicated his career to using innovative
technology to drive improved health and clinical outcomes," said Dr. Jonathan Rothberg, Chairman of Butterfly. "His
addition furthers my vision of combining the brightest talent with Butterfly's revolutionary Ultrasound-on-Chip technology, enhanced
through software and AI, to democratize medical imaging and drive accessible, affordable global health."
to the Butterfly Board of Directors almost three decades of medical and biomedical engineering experience and has co-founded
a number of technology companies. He is the Edward J. Poitras Professor in Medical Engineering and Science at the
Massachusetts Institute of Technology (MIT) and Professor of Medicine at Harvard Medical School, serving as well as a
practicing physician in the cardiac intensive care unit at Brigham and Women's Hospital in Boston.
Dr. Edelman and his laboratory have pioneered basic findings in vascular biology and the development and assessment of
biotechnology. He directs MIT's Institute for Medical Engineering and Science and Clinical Research Center. Dr. Edelman
is the founder and member of the board of directors of Autus Valve Technologies, Inc., BioDevek, Inc., and PanTher
"I have followed the adoption of Butterfly's technologies
around the world and am eager to partner with the Company to continue its mission to revolutionize patient care," said Dr.
Edelman. "This is a truly unique opportunity to have a meaningful impact in democratizing medical imaging."
At this exciting time in the company's journey, Butterfly
welcomes Ms. Pugh and Dr. Edelman to the passionate team behind its mission, vision and technology.
About Butterfly Network, Inc.
Founded by Dr. Jonathan Rothberg in 2011 and recently listed
on the NYSE through a merger with Longview Acquisition Corp, Butterfly created the world's first handheld, single probe whole-body
ultrasound system, Butterfly iQ. Butterfly's mission is to enable universal access to superior medical imaging, making
high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion
people around the world lacking access to ultrasound. Through its proprietary Ultrasound-on-Chip technology, Butterfly is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ
can be purchased online today by healthcare practitioners in the United States, Australia, Austria, Belgium, Canada, Denmark,
Finland, France, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland,
and the United Kingdom.